• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

可能是肺炎支原体的东西。

Things that could be Mycoplasma pneumoniae.

机构信息

Laboratory of Pediatrics, Erasmus MC-Sophia Children's Hospital, University Medical Center, Rotterdam, The Netherlands.

Laboratory of Pediatrics, Erasmus MC-Sophia Children's Hospital, University Medical Center, Rotterdam, The Netherlands; Division of Infectious Diseases and Hospital Epidemiology, and Children's Research Center (CRC), University Children's Hospital of Zurich, Zurich, Switzerland.

出版信息

J Infect. 2017 Jun;74 Suppl 1:S95-S100. doi: 10.1016/S0163-4453(17)30198-6.

DOI:10.1016/S0163-4453(17)30198-6
PMID:28646969
Abstract

M. pneumoniae infection gives rise to a wide variety of manifestations. The pathogenesis of secondary manifestations is not always known. Some depend on the direct invasion of M. pneumoniae and others on the indirect effect of M. pneumoniae through pathological immune responses, for instance autoreactive antibodies in Guillain-Barré Syndrome. Diagnosis remains challenging with currently available diagnostic tests, because they do not demonstrate a causal relation due to M. pneumoniae asymptomatic carriage or previous infection. The mainstay of treatment is macrolide antibiotics, but the role of additional immunomodulation therapy is unclear. Knowledge of the pathogenesis of the different manifestations should guide strategies for diagnosis and treatment.

摘要

肺炎支原体感染可引起多种表现。继发性表现的发病机制并不总是明确的。一些取决于肺炎支原体的直接侵袭,另一些则取决于肺炎支原体通过病理性免疫反应的间接作用,例如格林-巴利综合征中的自身反应性抗体。目前可用的诊断检测方法的诊断仍然具有挑战性,因为由于肺炎支原体无症状携带或既往感染,它们并不能证明因果关系。治疗的主要方法是大环内酯类抗生素,但额外免疫调节治疗的作用尚不清楚。对不同表现的发病机制的了解应指导诊断和治疗策略。

相似文献

1
Things that could be Mycoplasma pneumoniae.可能是肺炎支原体的东西。
J Infect. 2017 Jun;74 Suppl 1:S95-S100. doi: 10.1016/S0163-4453(17)30198-6.
2
Severe macrolide-resistant Mycoplasma pneumoniae pneumonia associated with macrolide failure.与大环内酯类药物治疗失败相关的严重耐大环内酯类肺炎支原体肺炎
J Microbiol Immunol Infect. 2016 Feb;49(1):127-30. doi: 10.1016/j.jmii.2014.11.003. Epub 2014 Nov 11.
3
Stevens-Johnson syndrome in a boy with macrolide-resistant Mycoplasma pneumoniae pneumonia.男孩患耐大环内酯类肺炎支原体肺炎合并史蒂文斯-约翰逊综合征。
Pediatrics. 2011 Jun;127(6):e1605-9. doi: 10.1542/peds.2010-2624. Epub 2011 May 2.
4
Clinical Characteristics of Macrolide-Resistant Mycoplasma pneumoniae from Children in Jeju.济州岛儿童中耐大环内酯类肺炎支原体的临床特征。
J Korean Med Sci. 2017 Oct;32(10):1642-1646. doi: 10.3346/jkms.2017.32.10.1642.
5
Current Mycoplasma pneumoniae outbreak: Don't forget its role in Bickerstaff encephalitis.当前肺炎支原体爆发:别忘记其在 Bickerstaff 脑炎中的作用。
Diagn Microbiol Infect Dis. 2024 Sep;110(1):116418. doi: 10.1016/j.diagmicrobio.2024.116418. Epub 2024 Jun 28.
6
[Servere atypical pneumonia with macrolide-resistant Mycoplasma pneumoniae].[重症非典型肺炎合并大环内酯类耐药肺炎支原体]
Ugeskr Laeger. 2018 Jul 23;180(30).
7
Mycoplasma pneumoniae infections--does treatment help?肺炎支原体感染——治疗有帮助吗?
J Infect. 2014 Nov;69 Suppl 1:S42-6. doi: 10.1016/j.jinf.2014.07.017. Epub 2014 Sep 26.
8
Fuchs syndrome associated with Mycoplasma pneumoniae (Stevens-Johnson syndrome without skin lesions).与肺炎支原体相关的富克斯综合征(无皮肤病变的史蒂文斯-约翰逊综合征)
Pediatr Dermatol. 2011 Jul-Aug;28(4):474-6. doi: 10.1111/j.1525-1470.2010.01200.x. Epub 2010 Jul 29.
9
Epidemic of Mycoplasma pneumoniae infection in Denmark, 2010 and 2011.2010 年和 2011 年丹麦肺炎支原体感染的流行。
Euro Surveill. 2012 Feb 2;17(5):20073. doi: 10.2807/ese.17.05.20073-en.
10
[Pathogenesis and laboratory diagnosis of Mycoplasma pneumoniae infections].[肺炎支原体感染的发病机制与实验室诊断]
Arch Pediatr. 2008 Jul;15(7):1253-6. doi: 10.1016/j.arcped.2008.02.010. Epub 2008 Apr 11.

引用本文的文献

1
Advances in adhesion-related pathogenesis in infection.感染中黏附相关发病机制的进展。
Front Microbiol. 2025 Jul 23;16:1613760. doi: 10.3389/fmicb.2025.1613760. eCollection 2025.
2
Resurgence of Mycoplasma pneumoniae infections in children: emerging challenges and opportunities.儿童肺炎支原体感染的再度流行:新出现的挑战与机遇
Curr Opin Infect Dis. 2025 Oct 1;38(5):468-476. doi: 10.1097/QCO.0000000000001126. Epub 2025 Aug 6.
3
Cold Agglutinin Syndrome Secondary to Mycoplasma pneumoniae Infection in Adults: Results From a Large French Observational Study (MyCOLD Study).
成人支原体肺炎感染继发冷凝集素综合征:一项大型法国观察性研究(MyCOLD研究)的结果
Am J Hematol. 2025 Sep;100(9):1557-1565. doi: 10.1002/ajh.70010. Epub 2025 Jul 19.
4
Recent Macrolide Resistance Pattern of Mycoplasma Pneumonia in the World: A Systematic Review and Meta-Analysis.全球肺炎支原体近期的大环内酯类耐药模式:一项系统评价与Meta分析
Iran J Public Health. 2025 Mar;54(3):530-541. doi: 10.18502/ijph.v54i3.18246.
5
Invades Non-Phagocytic Cells by Clathrin-Dependent Endocytic Pathways and Escapes from Phagocytic Vesicles.通过网格蛋白依赖的内吞途径侵入非吞噬细胞并从吞噬小泡中逃逸。
Pathogens. 2024 Nov 15;13(11):1003. doi: 10.3390/pathogens13111003.
6
An Atypical Presentation of Mycoplasma pneumoniae Infection Mimicking Acute Surgical Abdomen in an Adult.一名成人支原体肺炎感染的非典型表现酷似急性急腹症
Cureus. 2024 Nov 14;16(11):e73665. doi: 10.7759/cureus.73665. eCollection 2024 Nov.
7
Structure-Based Virtual Screening, ADMET Properties Prediction and Molecular Dynamics Studies Reveal Potential Inhibitors of HPrK/P.基于结构的虚拟筛选、ADMET性质预测及分子动力学研究揭示了HPrK/P的潜在抑制剂
Life (Basel). 2024 May 22;14(6):657. doi: 10.3390/life14060657.
8
Insights into the defensive roles of lncRNAs during infection.长链非编码RNA在感染过程中的防御作用洞察
Front Microbiol. 2024 Mar 22;15:1330660. doi: 10.3389/fmicb.2024.1330660. eCollection 2024.
9
Increased incidence of infections and hospital admissions in the Netherlands, November to December 2023.2023年11月至12月荷兰感染率和住院率上升。
Euro Surveill. 2024 Jan;29(4). doi: 10.2807/1560-7917.ES.2024.29.4.2300724.
10
A Case of Mycoplasma Infection with an Atypical Presentation of Abducens Nerve Palsy, Erythema Multiforme and Polyarthritis without Respiratory Manifestations.一株表现为展神经麻痹、多形红斑和多发性关节炎而无呼吸道表现的非典型性肺炎支原体感染病例。
Medicina (Kaunas). 2023 Dec 25;60(1):36. doi: 10.3390/medicina60010036.